School of Chinese Material Medica, Beijing University of Chinese Medicine, Yangguang South Road, Fangshan District, Beijing, China.
School of Chinese Material Medica, Beijing University of Chinese Medicine, Yangguang South Road, Fangshan District, Beijing, China.
Biomed Pharmacother. 2020 Nov;131:110700. doi: 10.1016/j.biopha.2020.110700. Epub 2020 Oct 7.
This study aimed to assess the effect and mechanism of i-type lysozyme on cutaneous wound healing animal model and Multiple cell models both in vivo and in vitro.
Therefore, to evaluate its regenerative efficacy on wound healing process, we daily applied i-type lysozyme on murine full-thickness excisional wounds. After sacrifice on indicated days, skin tissues around surgical defects were harvested and assessed for re-epithelialization, granulation tissue formation, neovascularization and remodeling. To elucidate the underlying mechanisms, i-type lysozyme was analyzed for its tissue regenerative potency on the proliferation, invasion, migration and tube formation against keratinocytes, fibroblasts and endothelial cells. Antioxidant and antimicrobial experiments were also conducted to elucidate protective ability of i-type lysozyme to wound bed.
It displayed excellent bi-directional regulation in wound repair, with significant acceleration of epidermal and dermal regeneration as well as the efficient attenuation of excessive collagen deposition and fibrosis in the surgical lesion. I-type lysozyme treatment augmented the proliferation and migration of HaCaT, NIH 3T3 and HUVECs, enhanced the invasion of HaCaT and HUVECs as well as accelerated tube formation of HUVECs. Additionally, it significantly recovered the proliferation of HO-damaged cells, whereas represented no microbicidal effect under effective concentration of wound healing.
Our findings demonstrate the bi-directional regulation of i-type lysozyme in wound healing process through promoting tissue regeneration while hampering scar formation, implying that it is a promising therapeutic agent for wound repair.
本研究旨在评估 i 型溶菌酶对动物模型和体内外多种细胞模型皮肤伤口愈合的作用和机制。
因此,为了评估其对伤口愈合过程的再生疗效,我们每天在小鼠全层切除伤口上应用 i 型溶菌酶。在指定天数处死动物后,采集手术缺损周围的皮肤组织,评估再上皮化、肉芽组织形成、新生血管形成和重塑情况。为了阐明其潜在机制,分析 i 型溶菌酶对角质形成细胞、成纤维细胞和内皮细胞的增殖、侵袭、迁移和管形成的组织再生能力。还进行了抗氧化和抗菌实验,以阐明 i 型溶菌酶对伤口床的保护能力。
它在伤口修复中表现出出色的双向调节作用,显著加速表皮和真皮的再生,并有效减轻手术损伤中过度的胶原沉积和纤维化。i 型溶菌酶处理增强了 HaCaT、NIH 3T3 和 HUVECs 的增殖和迁移,增强了 HaCaT 和 HUVECs 的侵袭能力,并加速了 HUVECs 的管形成。此外,它还显著恢复了 HO 损伤细胞的增殖,而在有效的伤口愈合浓度下,没有表现出杀菌作用。
我们的研究结果表明,i 型溶菌酶在伤口愈合过程中具有双向调节作用,通过促进组织再生而抑制瘢痕形成,这意味着它是一种有前途的伤口修复治疗剂。